Analysis | Metabolite Name | Measured Value | Units | Group |
---|---|---|---|---|
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.2215 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.2364 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.2371 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.2775 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.2902 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.3177 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.3320 | Peak area | Normal |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.3394 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.3433 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.3763 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.3764 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.3805 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.3827 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.4655 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.4901 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.5037 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.5112 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.5282 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.5577 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.5731 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.6010 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.6023 | Peak area | Normal |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.6147 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.6556 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.6659 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.7292 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.7477 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.7504 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.7513 | Peak area | Normal |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.7701 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.7798 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.7854 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.7880 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8001 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8195 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8227 | Peak area | Normal |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8277 | Peak area | Normal |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8329 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8417 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8543 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8551 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8670 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8739 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8836 | Peak area | Normal |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8847 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8902 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.8967 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.9278 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.9326 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.9530 | Peak area | Normal |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.9738 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.9741 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 0.9984 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.0016 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.0223 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.1027 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.1097 | Peak area | Normal |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.1116 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.1157 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.1348 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.1413 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.1496 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.1548 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.1750 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.1857 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.1877 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.2150 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.2599 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.2651 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.2869 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.2883 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.2914 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.3114 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.3202 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.3244 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.3249 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.3250 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.3432 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.3471 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.3522 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.3782 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.3844 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.3849 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.4137 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.4363 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.4605 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.4870 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.4983 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.5019 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.5045 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.5178 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.5211 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.5605 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.5981 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.7030 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.7208 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.7374 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.7717 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.8669 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 1.9204 | Peak area | Diabetic non neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 2.1056 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 2.1381 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 2.2208 | Peak area | Normal |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 2.2395 | Peak area | Diabetic Neuropathy |
HILIC POSITIVE ION MODE | phenylacetylglutamine | 2.4501 | Peak area | Diabetic Neuropathy |